Comparison of BioHPP (High Performance Polymer) - vs Titanium- vs Zirconia Abutments
NCT ID: NCT06737263
Last Updated: 2024-12-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
60 participants
INTERVENTIONAL
2019-02-13
2026-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Healing of Bone/Soft Tissue to Different Abutment Biomaterials and the Impact on Marginal Bone Loss
NCT01961635
A Comparison of Inflammatory Mediators Surrounding Titanium or Zirconium Implant Abutments
NCT01870349
Bio-HPP vs Cast Co-cr as Implant Framework
NCT05861388
A Comparison Between Protemp and Flowable Light Cure Composite Material for Creating Optimal Gingival Emergence Profile Around Implant
NCT07196293
Effect of Abutment Configuration on Peri-implant Soft and Hard Tissue in the Esthetic Zone - Randomized Clinical Trial
NCT06407271
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The patients are provided with closed healing dental implants. After 3 months, following implant exposure and optical impression, the implants are restored with individual abutments.
Follow-up appointments are scheduled at 3, 6, 12, 24, and 36 months after implantation. During these visits, implant healing is assessed based on clinical parameters such as probing depth, plaque index, mean bone level, and bleeding on probing.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BioHPP
High Performance Polymer as abutment material
BioHPP abutment
Patients in the test group receive abutments made of BioHPP
Titanium
Titanium as abutment material
Titanium abutment
Patients in the control group receive abutments made of titanium
Zirconia
Zirconia as abutment material
Zirconia abutment
Patients in the control group receive abutments made of zirconia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BioHPP abutment
Patients in the test group receive abutments made of BioHPP
Titanium abutment
Patients in the control group receive abutments made of titanium
Zirconia abutment
Patients in the control group receive abutments made of zirconia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patients must be between 18 and 99 years old.
* non-smokers, former smokers, or light smokers (fewer than 10 cigarettes per day).
* ASA ( American Society of Anesthesiologists) Class I or II.
* There must be no pregnancy or breastfeeding period.
* the patients must have an edentulous section of up to 3 teeth in the maxillary or mandibular region, where it is possible to place an implant
* no allergy to any of the study-related materials
Exclusion Criteria
* Heavy smokers or former heavy smokers who quit less than five years ago
* Existing pregnancy or breastfeeding period.
* Individuals classified as ASA Class III to V.
* Presence of a polymer allergy.
* Patients with severe systemic diseases, immune deficiencies, or on corticosteroid medication.
* Patients undergoing local radiation or bisphosphonate therapy.
* Patients requiring sinus augmentation or soft tissue augmentation.
* Participation in another dental study
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Graz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Oral Surgery and Radiology
Graz, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BioHPP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.